Sympathetic neurons display considerable plstict in the neurotrnmtter and neuropeptide phenotypes they express in viro and in wivo. The cholinergic differentiation factor (CDF, also known as leukemla inhibitory factor, LI)
the role of this factor in normal development, it is essential to determine where it is produced in situ. To lo CDF/LIF mRNA, a semiquantitative, reverse transcription-polymerase chain reaction method was employed. Actin ad tubulin mRNA were used as internal controls, and two different sets of CDF/LIF primers were compared. In patal rat peripheral tissues, CDF/LIF mRNA was selectively localize in the target area of developing, sympathetic cholinergic neurons; the mRNA was not detected in the targets of sympathetic noradrenergic neurons. This finding supports the hypothesis that CDF/LIF is a target-derived neuronal differentiation factor. In postnatal rat brain, CDF/LIF mRNA is azed selectively in two parts of the visual system, visual cortex and superior colliculus. Thus, CDF/LIF may play a role in this system as well.
Neuronal phenotype can be influenced by environmental factors (1) (2) (3) , and culture assays have been used to identify molecules that control phenotypic decisions. One such factor, cholinergic differentiation factor (CDF, also known as leukemia inhibitory factor, LIF; ref. 4) , is produced by certain cultured non-neuronal cells and switches the phenotype of cultured rat sympathetic neurons from noradrenergic to cholinergic (5) . This protein is known to affect the proliferation and differentiation of many cell types derived from the earliest embryo to the adult (6) . The pleiotropic effects of this cytokine revealed in vitro raise the question of how and where it acts in vivo. Moreover, since a number of distinct proteins can induce cultured sympathetic neurons to become cholinergic (7) (8) (9) (10) , it is essential to determine where and when CDF/LIF and the other factors are produced in situ.
The sweat glands of the rat footpad are well-known targets for cholinergic sympathetic neurons. During normal development, noradrenergic sympathetic neurons are converted to the cholinergic phenotype at the time their axons innervate the glands (11) . Moreover, footpads containing sweat glands can induce noradrenergic sympathetic neurons that normally innervate other targets in hairy skin to become cholinergic, when the pads are transplanted to an ectopic site in the hairy skin (12, 13) . In addition, extracts of footpads contain an activity that converts cultured sympathetic neurons from noradrenergic to cholinergic (14) . Therefore, sweat glands represent a target tissue in which CDF/LIF could be localized in vivo. Furthermore, since CDF/LIF can also enhance the cholinergic properties of cultured central nervous system neurons (15) , it is also important to study the distribution of this factor in the brain.
While it is possible to detect a CDF/LIF mRNA band in total RNA from cultured heart cells ( (17) .
MATERIALS AND METHODS
RNA Preparatio and PCR. Total RNA was extracted by the acid/phenol method (18) from the tissues described. The amount of total RNA was estimated by the DipStick system (Invitrogen); 0.5 gg of total RNA was used for the cDNA reactions. The volume of the cDNA reaction mixture, containing random primer (pN6; ref. 19 of total RNA from adult rat heart tissue, added before cDNA synthesis. This dose-response curve was quite similar to that obtained in the absence of added heart RNA (data not shown). Thus the detection limit of the assay is between 0.05 and 1 pg per sample under these conditions. Additional dilution experiments indicate that the limit is usually 0.2 pg. These results also demonstrate that the absence of a positive CDF/LIF mRNA signal in adult heart (lane 10) is not likely to be due to an inhibitor ofthe PCR process; that is, the result is not a false negative.
CDF/LIF Is Specifically Expressed in Footpads. A positive CDF/LIF mRNA signal was obtained from the rat footpad, a target of cholinergic sympathetic neurons. Total RNA from P8 and P16 footpads (Fig. 1B, lanes 4 (Fig. 1B, lanes 2 and 3) . The significant a-tubulin signal generated from the same RNA preparations (Fig. 1B, lanes 2  and 3, lower arrowhead) argues that the lack of a CDF/LIF band was not due to a gross deficiency in total mRNA. The lack of a CDF/LIF mRNA signal in the samples from connective tissue and hairy skin is important because footpads contain connective tissue and epidermis in addition to sweat glands. Thus, these results suggest that the CDF/LIF mRNA is indeed localized to the sweat glands.
CDF/LIF mRNA was also not detected in other P8 targets of noradrenergic sympathetic neurons. Examples of such tissues are lacrimal and submaxillary glands (Fig. 1C, lanes  1 and 5; Fig. 2B, lanes 1 and 6) , liver ( Fig. 2A, lane 5; Fig. 2B,  lanes 4, 7, 8, and 10; Fig. 2C, lane 4) , parotid gland (Fig. 2C,  lane 1) , and in vivo heart tissue ( Fig:t A, lane 10 ; Fig. 2A,  lanes 1 and 2; Fig. 2C, lane 3) . In addition, no CDF/LIF signal was detected in P8 gut (Fig. 1C, (Fig. LA, lanes 1-3; Fig, 2C, lanes 6 and 7) . Therefore, these results indicate that the-targets of noradrenergic sympathetic neurons and-the targets of other cholinergic neurons (enteric and spinal motor) do not contain detectable CDF/LIF mRNA, at least at P8.
The sympathetic neurons that innervate the sweat glands undergo the noradrenergic-to-cholinergic conversion after their axons reach the footpads, beginning in the second postnatal week (11) . To determine whether CDF/LIF mRNA is present in the footpads during this critical time, extracts were made at several ages (Fig. iD) . The relative intensity of the CDF/LIF bands (upper gel) compared with those of 3-actin (lower gel) generated from the same samples indicates that CDF/LIF mRNA levels are at their highest during the time of initial innervation (P8, lane 2). The level prior to innervation (P4, lane 1) appears to be less than at P8 and the signal appears to decline following P8 (lanes [3] [4] [5] . Given the semiquantitative nature ofthe RT-PCR assay, these apparent changes in CDF/LIF mRNA levels are necessarily tentative. Nonetheless, similar results were obtained in three independent experiments, including one using a different set of primers for the CDF/LIF mRNA.
In the latter case, an alternative 3' primer that covers only part of the second exon was used. When this primer plus the 5' primer previously employed were used, two bands were observed from the PCR with footpad RNA. One band was of the size expected for CDF/LIF (396 bp). The other band was w1100 bp, the size expected for an exon-intron-exon sequence (data not shown). As described in Materials and Methods, obtaining a band of the expected size with two independent sets of CDF/LIF primers is important support for the identity of the RT-PCR band from sweat-gland extracts. The fact that the primer that spans the second and third exons yielded only the lower band provides additional evidence that the CDF/LIF band was not generated from genomic templates.
CDF/LIF Expression In Brain. Since a CDF/LIF mRNA band could be reliably detected in select peripheral tissues, the same method was employed for a number of brain areas. While a clear CDF/LIF mRNA band was found in extracts from adult visual cortex and P17 superior colliculus (Fig. 3A) , no signal was detected in samples from various postnatal ages of hippocampus ( Fig. 2A, lanes 3 and 4) , frontal cortex, olfactory bulb, cerebellum, basal forebrain, and ventral brainstem (Fig. 3B) . The data in Fig. 3 A andB come from the same experiment, and actin mRNA was used as the internal control to normalize the relative amounts of RNA in the tissue samples. Since there were several bands present in some of the samples from the CDF/LIF PCR, a second CDF/LIF primer (5'-CAATGCCCTCTTTATITCCTATI7A-CACAGC-3') was used in further experiments on these various brain areas. No bands were detected in the size range expected for CDF/LIF in the brain areas represented in Fig.  3B , whereas the CDF/LIF band was again observed in extracts of adult visual cortex (data not shown).
DISCUSSION
A positive CDF/LIF signal was detected in footpad RNA and not in a number of other tissues from postnatal rat. This indicates that the RT-PCR method has not simply amplified an extremely rare mRNA that is uniformly present in all tissues, nor is it likely that the positive signal in footpads represents contamination or a PCR artifact (23) (24) (25) (26) . The ratio of the signal in sweat gland to that in the tissues where no signal was detected is estimated to be at least 20:1 (5-10 pg in P8 footpads and a detection limit of 0.2 pg). It is of interest that postnatal heart tissue RNA does not contain detectable CDF/LIF mRNA, whereas cultured heart cell RNA does. It is known that production of CDF/LIF by heart cells is under hormonal control (27) . The result with heart tissue in vivo is consistent with the fact that sympathetic neurons that innervate the heart are noradrenergic. All of the other targets of noradrenergic sympathetic neurons tested were also negative for CDF/LIF mRNA (lacrimal, parotid and submaxillary glands, liver, and hairy skin; the level of RNA in the parotid sample was low, however). Thus, there is a strong correlation between the presence of CDF/LIF in peripheral tissues and the phenotype of the sympathetic neurons innervating these tissues (Table 1 ). In addition, the lack ofdetectable CDF/LIF mRNA in heart and gut may indicate that this factor is not responsible for the cholinergic phenotype of the parasympathetic neurons that are found in these tissues. These conclusions must remain tentative, however, until samples from embryos are tested. The apparent developmental regulation of the signal in footpads (Fig. 1D) illustrates the importance ofthis qualification. Moreover, the cholinergic innervation of the other muscles and glands tested occurs during embryonic development, in contrast to the postnatal innervation of the sweat gland.
The present results should also be integrated with those of Rao and Landis (14) . They have found that footpad homogenates contain a factor(s) that induces cholinergic differentiation in cultured sympathetic neurons. Most of this cholinergic activity is not, however, precipitated with an antiserum generated against the N-terminal region of CDF, nor is the chromatographic behavior of the activity in the homogenate identical to that of CDF purified from cultured heart cells. These results suggest that the cholinergic factor in the footpads may not be CDF/LIF (14) (29, 30) , it was of interest to determine whether its mRNA could be detected in the brain. Since the factor can alter the expression of many neuropeptides and transmitters, and the particular genes affected depend on the neurons being tested (30) , it was important to assay many brain areas, notjust those receiving projections from the cholinergic basal forebrain (31) . Summarizing the results obtained thus far with brain, Table 1 shows that CDF/LIF mRNA levels are much higher in visual cortex and superior colliculus than in other brain areas. Therefore, the presence of the factor in postnatal brain does not directly correlate with the presence of a cholinergic projection from the basal forebrain. This does not preclude that such a correlation may be found in embryonic brain, however. The relatively late appearance of detectable CDF/ LIF mRNA in the visual system is unexplained at present. Perhaps this factor is involved in an as yet undescribed postnatal phenotypic plasticity. It is also possible that the factor plays an entirely different role, unrelated to that established in the peripheral nervous system. Phenotypic plasticity has, however, been demonstrated for neurons from various brain areas (e.g., refs. 32 and 33). While it is also possible that the presence of the mRNA does not connote the production of the CDF/LIF protein, the strong correlation of the CDF/LIF mRNA with a particular neuronal phenotype in the sympathetic system suggests that the presence of this message in the visual system is indeed meaningful. 
